Ensuring Diversity & Inclusion for Clinical Trials

Return to Insights Center

Related Insights

Blog

Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression

Apr 23, 2024

Article

3 ways to incorporate DE&I in your communications strategy

Sep 29, 2021

Blog

Parexel names first Patient Ambassador

Jun 17, 2022

Blog

Patient Advocacy Groups: A vital partner for sponsors that understand how to engage with patients

May 3, 2022

Blog

Patients as Partners 2022: Moving from Insights to Action

May 3, 2022

Blog

Toward more inclusive studies: Reaching and retaining patients from underrepresented communities

Apr 25, 2022

Podcast

Decentrally Speaking | Episode 1: Optimizing Trial Inclusivity For Patients From Under-Represented Communities

Mar 22, 2022

Video

Part 2: Risk-based Quality Management Video (RBQM) Series

Nov 11, 2021

Blog

Actigraphy advances a patient-first approach: Reduce patient burden — and make the most of valuable data

Oct 15, 2021

Blog

Highlights from ISMPP Asia Pacific Meeting 2021

Sep 20, 2021

Video

Parexel Site Alliances

Jul 13, 2022

Article

Three ways to work with the FDA for better patient-focused trials

Jul 29, 2021